Ceftazidime Pentahydrate 1000mg Injection — Dry Powder Injections
WHO-GMP Certified Commercial Pack · Product Code: AKP-042

Ceftazidime Pentahydrate 1000mg Injection

Formulation Overview: High-potency sterile third-generation antipseudomonal cephalosporin dry powder vial engineered in ISO Class 5 suites for ICU gram-negative systemic infections. Formulated with Ceftazidime Pentahydrate USP / IP (eq. Anhydrous Ceftazidime 1000 mg) (1000 mg (1 g)) in Sterile Dry Powder Injection Vial dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 1g Clear USP Type I Glass Vial + 10 ml WFI Ampoule in Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-042
Therapeutic SectorAnti-Infectives & Antibiotics
Dosage FormSterile Dry Powder Injection Vial
Active IngredientCeftazidime Pentahydrate USP / IP (eq. Anhydrous Ceftazidime 1000 mg)
Strength / Purity1000 mg (1 g)
Clinical IndicationPseudomonas aeruginosa bacteremia, febrile neutropenia, meningitis, and hospital pneumonia
Specification StandardIP / BP / USP Compendial
Packaging Format1g Clear USP Type I Glass Vial + 10 ml WFI Ampoule in Carton
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; protect from light; use reconstituted solution within recommended window
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Dry Powder Injections & Anti-Infectives & Antibiotics